VivoSeq
Other

Critically Ill

2

Pipeline Programs

8

Active Trials

3

Companies Involved

Critically Ill is an early-stage landscape with 2 programs across 3 companies. The most active players are Fresenius Kabi Oncology Ltd., AstraZeneca, GSK. 2 programs are in Phase 3.

Pipeline Metrics

Competitive Density

29/100

Pipeline Velocity

19/100

Mech. Concentration

100/100

Completion Rate

77/100

Attrition Rate

16/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Approved
No programs

Trial Status

44

clinical trials

Completed23 · 52%
Recruiting6 · 14%
Unknown status6 · 14%
Terminated4 · 9%
Withdrawn3 · 7%
Not yet recruiting2 · 5%

Trial Activity

44 trials

Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
Recruiting··N/A·NCT05055830·2,000 enrolled
Intravenous Fish Oil in Critically Ill Cardiac Patients
Completed··Phase 3·NCT00516178·31 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)